Literature DB >> 7626348

Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.

V V Bonarjee1, T Omland, D W Nilsen, K Caidahl, J A Sundsfjord, K Dickstein.   

Abstract

OBJECTIVES: (a) To assess the relation between plasma concentrations of proatrial natriuretic factor (1-98) and non-invasively derived indices of left ventricular systolic and diastolic performance and (b) to assess the potential confounding effect of renal function and age on this relation in patients with acute myocardial infarction.
DESIGN: Cross sectional comparison of biochemical and echocardiographic indices of cardiac function.
SETTING: Norwegian central hospital. PATIENTS: Sixty four patients with acute myocardial infarction. MAIN OUTCOME MEASURES: Relation between plasma proatrial natriuretic factor (1-98) concentrations and echocardiographic indices of left ventricular systolic function as assessed by univariate and multivariate linear regression analysis. Sensitivity and specificity of plasma proatrial natriuretic factor (1-98) concentration as a measure of left ventricular systolic and diastolic dysfunction.
RESULTS: Plasma proatrial natriuretic factor (1-98) concentrations were significantly related to left ventricular ejection fraction (r = -0.33; P = 0.008), age (r = 0.43; P < 0.001), and creatinine clearance (r = - 0.53; P < 0.001). In a multivariate model left ventricular ejection fraction and creatinine clearance were both independently related to plasma values. The mean concentration of proatrial natriuretic factor (1-98) was significantly higher in patients with an ejection fraction of < 40% than in those with an ejection fraction of > or = 40% (1876 (1151) v 1174 (530) pmol/l; P = 0.03) and in patients with an abnormal transmitral E/A ratio ( < 0.65 or > 1.65, where E/A is ratio of peak early filling velocity to peak atrial component) compared with those with a normal ratio (1572 (895) v 1137 (523) pmol/l, respectively; P = 0.02). When patients were subdivided according to the median concentration of proatrial natriuretic factor (1192 pmol/l) the sensitivity and specificity were 89% and 56% respectively for detecting a left ventricular ejection fraction of < 40% and 75% and 61% respectively for detecting an abnormal E/A ratio. Concentrations below the median had a negative predictive value of 97% in excluding an ejection fraction of < 40% and of 84% in excluding an abnormal E/A ratio.
CONCLUSION: These results suggest that soon after myocardial infarction left ventricular ejection fraction and indices of renal function are independently related to plasma concentrations of proatrial natriuretic factor (1-98). Plasma concentrations of proatrial natriuretic factor (1-98) seem to reflect renal and cardiac performance rather than specific haemodynamic variables assessed by noninvasive methods. Plasma proatrial natriuretic factor (1-98) measurements may be a useful screening tool to identify patients with normal cardiac function soon after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626348      PMCID: PMC483911          DOI: 10.1136/hrt.73.6.511

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  26 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Importance of adjusting left ventricular diastolic peak filling rate for heart rate.

Authors:  R Danielsen; J E Nordrehaug; H Vik-Mo
Journal:  Am J Cardiol       Date:  1988-02-15       Impact factor: 2.778

3.  Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

Authors:  J A Sundsfjord; G Thibault; P Larochelle; M Cantin
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

4.  Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function.

Authors:  P Spirito; B J Maron
Journal:  Br Heart J       Date:  1988-06

5.  Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.

Authors:  M G Buckley; G A Sagnella; N D Markandu; D R Singer; G A MacGregor
Journal:  Clin Sci (Lond)       Date:  1989-11       Impact factor: 6.124

6.  Clearance function of type C receptors of atrial natriuretic factor in rats.

Authors:  F A Almeida; M Suzuki; R M Scarborough; J A Lewicki; T Maack
Journal:  Am J Physiol       Date:  1989-02

7.  N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

Authors:  C Hall; J L Rouleau; L Moyè; J de Champlain; D Bichet; M Klein; B Sussex; M Packer; J Rouleau; M O Arnold
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

8.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

9.  The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor.

Authors:  G Thibault; R Garcia; J Gutkowska; J Bilodeau; C Lazure; N G Seidah; M Chrétien; J Genest; M Cantin
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

10.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.

Authors:  A E Raine; P Erne; E Bürgisser; F B Müller; P Bolli; F Burkart; F R Bühler
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

View more
  4 in total

Review 1.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

2.  N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.

Authors:  F M Fruhwald; A Fahrleitner; N Watzinger; H Dobnig; M Schumacher; R Maier; R Zweiker; G Leb; W Klein
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

3.  Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction.

Authors:  P Bettencourt; A Ferreira; N Pardal-Oliveira; M Pereira; C Queirós; V Araújo; M Cerqueira-Gomes; M J Maciel
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

4.  Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.

Authors:  Bong Geun Song; Eun Seok Jeon; Yong Hoon Kim; Min Kyung Kang; Joon Hyung Doh; Phil Ho Kim; Seok Jin Ahn; Hye Lim Oh; Hyun-Joong Kim; Ji Dong Sung; Sang Chol Lee; Hyeon Cheol Gwon; June Soo Kim; Duk-Kyung Kim; Sang Hoon Lee; Kyung Pyo Hong; Jeong Euy Park; Soo Youn Lee; Jong Koo Lee
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.